Wealth Way Finder
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Wealth Way Finder

Politics

Pro-Israel Dem says those who won’t decry Hamas over Oct. 7 attack ‘have no business’ posing as humanitarians

by admin July 24, 2025
July 24, 2025
Pro-Israel Dem says those who won’t decry Hamas over Oct. 7 attack ‘have no business’ posing as humanitarians

Rep. Ritchie Torres, D-N.Y., an outspoken opponent of antisemitism, said Wednesday that those who refuse to speak out against the heinous acts Hamas perpetrated in Israel on Oct. 7, 2023 ‘have no business’ claiming to be humanitarians.

‘If you refuse to condemn Hamas for the murder, maiming, mutilation, rape, torture, and abduction of thousands of Jews and Israelis on October 7, then you have no business calling yourself a humanitarian,’ Torres wrote on X. 

‘A humanitarianism that devalues Jewish life is no humanitarianism at all, for it has been hollowed out by antisemitism,’ he added.

The congressman has been a strong voice of support for Israel.

‘The singular stumbling block to ending the war is the terrorist organization that barbarically began it: Hamas. Scapegoating Israel is so second nature to the international community that Hamas’ role in precipitating and perpetuating the war has been all but forgotten,’ Torres wrote on X earlier this month.

In another post on X this month he opined that ‘Antisemitism is the deadliest disease ever to afflict the human heart.’

In a post last month, he asserted, ‘If Israel is the sole country in the Middle East—indeed the world—for which you reserve the label ‘apartheid’—then your use of the term is probably propagandistic rather than principled and your purpose is not constructive criticism but the destructive delegitimation of Israel as a Jewish State.’

Torres has served in the U.S. House of Representatives since early 2021.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
White House Unveils 90 Point AI Strategy
next post
UnitedHealth says it faces DOJ investigation over Medicare billing practices

Related Posts

DNI Tulsi Gabbard declassified Trump-Russia docs: Here’s what...

July 27, 2025

House Republicans unveil new food stamp work requirements...

May 13, 2025

Trump downplays signs of MAGA unrest over possible...

June 19, 2025

Democrats begin to embrace Musk amid Trump spat...

June 6, 2025

Netanyahu calls on Iranian citizens to seize ‘opportunity’...

June 15, 2025

MORNING GLORY: Trump meets Putin amid an era...

August 12, 2025

Several provisions fail to pass muster with Senate...

June 21, 2025

David Gergen, trusted White House advisor to 4...

July 12, 2025

China is exploiting our government’s tech weakness. We...

July 14, 2025

Family matters: How VP Vance, wife deliver ‘normalcy...

May 4, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (101)
    • Investing (184)
    • Politics (212)
    • World (148)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: wealthwayfinder.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 wealthwayfinder.com | All Rights Reserved